Measurement of the antibiotic susceptibility of Coxiella burnetii using real time PCR

International Journal of Antimicrobial Agents

Volumn 23, Issue 2, 2004, Pages 169-174

  Boulos, Areen ^a   Rolain, Jean Marc ^a   Maurin, Max ^a   Raoult, Didier ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Antibiotic susceptibility; Coxiella burnetii; Q fever; Real time PCR

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; MACROLIDE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TELITHROMYCIN; THIAMPHENICOL;

ACCURACY; ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; COXIELLA BURNETII; DOSE RESPONSE; DRUG EFFICACY; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION;

EID: 0842307109     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.07.007     Document Type: Article

References (28)

1. Maurin M., Benoliel A.M., Bongrand P., Raoult D. Phagolysosomes of Coxiella burnetii - infected cell lines maintain an acidic pH during persistent infection. Infect. Immun. 60:1992;5013-5016.
2. Maurin M., Raoult D. Q fever. Clin. Microbiol. Rev. 12:1999;518-553.
3. Christopher G.W., Cieslak T.J., Pavlin J.A., Eitzen E.M. Jr. Biological warfare. A historical perspective. JAMA. 278:1997;412-417.
4. Greenfield R.A., Drevets D.A., Machado L.J., Voskuhl G.W., Cornea P., Bronze M.S. Bacterial pathogens as biological weapons and agents of bioterrorism. Am. J. Med. Sci. 323:2002;299-315.
5. Maurin M., Raoult D. Optimum treatment of intracellular infection. Drugs. 52:1996;45-59.
6. Raoult D., Torres H., Drancourt M. Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii. Antimicrob. Agents Chemother. 35:1991;2070-2077.
7. Maurin M., Raoult D. In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetii to clarithromycin. Antimicrob. Agents Chemother. 37:1993;2633-2637.
8. Rolain J.M., Maurin M., Bryskier A., Raoult D. In vitro activities of telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowasekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis. Antimicrob. Agents Chemother. 44:2000;1391-1393.
9. Siegman-Igra Y., Kaufman O., Keysary A., Rzotkiewicz S., Shalit I. Q fever endocarditis in Israel and a worldwide review. Scand. J. Infect. Dis. 29:1997;41-49.
10. Raoult D., Houpikian P., Tissot Dupont H., Riss J.M., Arditi-Djiane J., Brouqui P. Treatment of Q fever endocarditis: comparison of two regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch. Int. Med. 159:1999;167-173.
11. Maurin M., Benoliel A.M., Bongrand P., Raoult D. Phagolysosomal alkalinization an the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. J. Infect. Dis. 166:1992;1097-1102.
12. Brouqui P., Raoult D. Endocarditis due to rare and fastidious bacteria. Clin. Microbiol. Rev. 14:2001;177-207.
13. Calza L., Attard L., Manfredi R., Chiodo F. Doxycycline and chloroquine as treatment for chronic Q fever endocarditis. J. Infect. 45:2002;127-129.
14. Gikas A., Spyridaki I., Psaroulaki A., Kofterithis D., Tselentis Y. In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. Antimicrob. Agents Chemother. 42:1999;2747-2748.
15. Rolain J.M., Maurin M., Raoult D. Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii. Antimicrob. Agents Chemother. 45:2001;301-302.
16. Rolain J.M., Stuhl L., Maurin M., Raoult D. Evaluation of antibiotic susceptibilities of three rickettsial species including Rickettsia felis by a quantitative PCR DNA assay. Antimicrob. Agents Chemother. 46:2002;2747-2751.
17. Fenollar F., Maurin M., Raoult D. Wolbachia pipientis Growth kinetics and susceptibilities to 13 antibiotics determined by immunofluorescence staining and real time PCR. Antimicrob. Agents Chemother. 47:2003;1665-1671.
18. Masselot F., Boulos A., Maurin M., Rolain J.M., Raoult D. Molecular evaluation of antibiotic susceptibility, the Tropheryma whipplei paradigm. Antimicrob. Agents Chemother. 47:2003;1658-1664.
19. Brennan R.E., Samuel J.E. Evaluation of Coxiella burnetii antibiotic susceptibilities by real time PCR Assay. J. Clin. Microbiol. 41:2003;1869-1874.
20. Raoult D., Drancourt M., Vestris G. Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells. Antimicrob. Agents Chemother. 34:1990;1512-1514.
21. Stein A., Raoult D. Detection of Coxiella burnetii by DNA amplification using polymerase chain reaction. J. Clin. Microbiol. 30:1992;2462-2466.
22. Higgins D.G., Sharp P.M. Clustal: a package for performing multiple sequence alignment on a microcomputer. Gene. 73:1988;237-244.
23. Levy P.Y., Drancourt M., Etienne J., Auvergnat J.C., Beytout J., Sainty J.M.et al. Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis. Antimicrob. Agents Chemother. 35:1991;533-537.
24. Rolain JM, Mallet MN, Raoult D, Correlation between serum levels of doxycycline and serology evolution in patients treated for Coxiella burnetii endocarditis, J Infect Dis 2003;188(9):1322-25.
25. Yeaman M.R., Mitscher L.A., Baca O.G. In vitro susceptibility of Coxiella burnetii to antibiotics, including several quinolones. Antimicrob. Agents Chemother. 31:1987;1079-1084.
26. Spyridaki I., Gikas A., Kofteridis D., Psaroulaki A., Tselentis Y. Q fever in the greek island of Crete: detection, isolation, and molecular identification of eight strainsof Coxiella burnetii from clinical samples. J. Clin. Microbiol. 36:1998;2063-2067.
27. Jabarit-Aldighieri N., Torres H., Raoult D. Susceptibility of R. conorii, R. rickettsii and C. burnetii to CI- 960 (PD 127,391), PD 131,628, pefloxacin, ofloxacin and ciprofloxacin. Antimicrob. Agents Chemother. 36:1992;2529-2532.
28. Maurin M, Raoult D. Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, 'Israeli spotted fever group rickettsia' and Coxiella burnetii. J Antimicrob Chemother 1997;39:725-30.